The Value of Focus
In this episode, our guest is Josh Hattem discussing insights from recent research on the value of focus in portfolio strategy for biopharmaceutical companies. Highlights from the episode include: - Defining what is a portfolio strategy within a biopharmaceutical company - Why focus can provide a competitive edge but companies often fail to maximize the benefits - Implications on how to align R&D and commercial strategy to drive pipeline investment and greater commercial success Additional details – Article published on InVivo (March 2021) https://invivo.pharmaintelligence.informa.com/IV124716/The-Value-And-Challenge-Of-Focus-In-Pharma Hosted by: Jennifer Curtis Produced by: Matilda Males Featuring: Joshua Hattem